[Double-blind collaborative study of centrophenoxine versus placebo in patients with neurasthenic syndromes].
D000328:Adult; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D005260:Female; D006016:Glycolates / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D002504:Meclofenoxate / Q000009:adverse effects / Q000627:therapeutic use*; D008875:Middle Aged; D009440:Neurasthenia / Q000188:drug therapy* / Q000523:psychology; D011581:Psychological Tests
D006016:Glycolates; D002504:Meclofenoxate
Doppelblinde Verbundstudie Centrophenoxin versus Plazebo bei Patienten mit neurasthenischen Syndromen.